According to Deep Tide TechFlow news, the official information disclosure system of the Hong Kong Stock Exchange shows that on July 17, Huajian Medical (01931.HK) announced the official launch of the 'IVDNewCo Exchange' ecological plan, introducing the world's first RWA exchange ecosystem focused on high-tech assets for medical innovative drugs and issuing the IVDD stablecoin plan.
It is reported that the company is actively promoting a milestone strategic initiative to build an exchange ecosystem centered on high-tech assets for medical innovative drugs, named 'NewCo + RWA + Web3' trading ecosystem, which will be called 'IVDNewCo Exchange' and will issue a proprietary stablecoin (IVDDollar 'IVDD').
This strategy aims to disrupt the traditional rules of the pharmaceutical industry by integrating Web3 technology (including RWA real-world asset tokenization, blockchain trading, and stablecoin mechanisms) to enhance the liquidity, financing efficiency, and accessibility of global medical innovative drug assets. The following will elaborate on the strategic concept, progress, advantages, and future plans of this ecosystem.